Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium tuberculosis | 15 | 2025 | 406 | 3.280 |
Why?
|
| Tuberculosis, Pulmonary | 11 | 2024 | 111 | 2.390 |
Why?
|
| Lung | 9 | 2024 | 952 | 1.660 |
Why?
|
| Macrophages, Alveolar | 4 | 2024 | 64 | 1.200 |
Why?
|
| Tuberculosis Vaccines | 7 | 2020 | 30 | 1.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2025 | 674 | 1.160 |
Why?
|
| Tuberculosis | 4 | 2025 | 295 | 1.070 |
Why?
|
| Th1 Cells | 2 | 2018 | 174 | 0.940 |
Why?
|
| Mycobacterium bovis | 2 | 2023 | 28 | 0.860 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2024 | 641 | 0.810 |
Why?
|
| Dendritic Cells | 2 | 2018 | 524 | 0.800 |
Why?
|
| Mice, Inbred C57BL | 4 | 2025 | 3387 | 0.670 |
Why?
|
| Immunity, Mucosal | 3 | 2017 | 52 | 0.630 |
Why?
|
| CD11b Antigen | 1 | 2018 | 19 | 0.570 |
Why?
|
| Integrin alpha Chains | 1 | 2018 | 11 | 0.570 |
Why?
|
| Interleukin-10 | 1 | 2018 | 160 | 0.530 |
Why?
|
| Immunization | 3 | 2017 | 131 | 0.520 |
Why?
|
| Antigens, CD | 1 | 2018 | 347 | 0.510 |
Why?
|
| Immunity, Innate | 4 | 2020 | 796 | 0.510 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2015 | 62 | 0.470 |
Why?
|
| BCG Vaccine | 3 | 2023 | 51 | 0.460 |
Why?
|
| T-Lymphocytes | 4 | 2019 | 1007 | 0.450 |
Why?
|
| Macrophages | 3 | 2025 | 1038 | 0.410 |
Why?
|
| Mice | 14 | 2025 | 10816 | 0.410 |
Why?
|
| Animals | 15 | 2025 | 20610 | 0.330 |
Why?
|
| Respiratory Mucosa | 5 | 2018 | 53 | 0.270 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2025 | 109 | 0.240 |
Why?
|
| Lymph Nodes | 2 | 2018 | 224 | 0.230 |
Why?
|
| Antigens, Bacterial | 4 | 2019 | 199 | 0.220 |
Why?
|
| Genetic Background | 1 | 2023 | 6 | 0.210 |
Why?
|
| Vaccination | 3 | 2019 | 363 | 0.190 |
Why?
|
| Acyltransferases | 2 | 2019 | 31 | 0.160 |
Why?
|
| Antitubercular Agents | 1 | 2019 | 82 | 0.150 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 113 | 0.140 |
Why?
|
| Receptors, CXCR3 | 1 | 2017 | 35 | 0.140 |
Why?
|
| Female | 7 | 2024 | 32709 | 0.120 |
Why?
|
| Interferon-gamma | 3 | 2025 | 566 | 0.120 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 760 | 0.120 |
Why?
|
| Humans | 9 | 2024 | 63152 | 0.120 |
Why?
|
| Administration, Inhalation | 1 | 2015 | 151 | 0.110 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 1275 | 0.110 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 2179 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 176 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 261 | 0.100 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 574 | 0.100 |
Why?
|
| Immune Evasion | 1 | 2012 | 68 | 0.090 |
Why?
|
| Immunologic Memory | 3 | 2018 | 288 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 3 | 2018 | 881 | 0.080 |
Why?
|
| Vaccines, Synthetic | 2 | 2020 | 74 | 0.080 |
Why?
|
| Time Factors | 2 | 2014 | 3754 | 0.080 |
Why?
|
| Adoptive Transfer | 2 | 2017 | 148 | 0.060 |
Why?
|
| Granzymes | 1 | 2025 | 21 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2015 | 5625 | 0.050 |
Why?
|
| Cell Movement | 2 | 2017 | 450 | 0.050 |
Why?
|
| Genetic Vectors | 2 | 2019 | 871 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2017 | 2107 | 0.040 |
Why?
|
| Administration, Mucosal | 1 | 2020 | 2 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 93 | 0.040 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2019 | 12 | 0.040 |
Why?
|
| Administration, Intranasal | 1 | 2019 | 27 | 0.040 |
Why?
|
| Nasal Mucosa | 1 | 2019 | 18 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2019 | 18 | 0.040 |
Why?
|
| Pan troglodytes | 1 | 2019 | 32 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 37 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2019 | 71 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 75 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2019 | 121 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 371 | 0.040 |
Why?
|
| Genotype | 1 | 2019 | 664 | 0.030 |
Why?
|
| Leukocytes | 1 | 2017 | 104 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 2017 | 135 | 0.030 |
Why?
|
| Monocytes | 1 | 2018 | 353 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 718 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 2015 | 99 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 2152 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 520 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 765 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2015 | 660 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2012 | 178 | 0.020 |
Why?
|
| Mycobacterium smegmatis | 1 | 2012 | 67 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 101 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1559 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 3033 | 0.020 |
Why?
|
| Male | 2 | 2019 | 29717 | 0.020 |
Why?
|